Effects of TOTUM-448 on Liver Fat Content, Cardiometabolic Risk Factors and Gut Microbiota Among Participants with MASLD

NCT06704321 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Alcoholic Fatty Liver Disease

Interventions

DIETARY_SUPPLEMENT: TOTUM-448
DIETARY_SUPPLEMENT: Placebo

Sponsor

Valbiotis

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]